Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Rol van IFN-gamma bij immuuntherapie voor kanker
jun 2020 | Immuuntherapie